Ultrasonographic Measurement of Severe Sarcopenia in the Elderly Subject.
Emeline Michel, Vincent Sarrazy, Fréderic Chorin and 4 others
PMID 40130743WHAT IT FOUND
Ultrasound measurement of rectus femoris thickness significantly distinguished severe from non-severe sarcopenia in elderly patients.
A thickness of 10.3 mm or less identified severe cases with 89% sensitivity, offering a rapid, accessible bedside tool for assessing functional decline.
Key findings
01Patients with severe sarcopenia had significantly thinner rectus femoris muscles (12.44 mm) compared to those with non-severe sarcopenia (13.92 mm).
02A rectus femoris thickness cutoff of 10.3 mm detected severe sarcopenia with 89% sensitivity and 35.2% specificity.
03In logistic regression, age and rectus femoris thickness were the only significant predictors of severe sarcopenia status.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study did not use a gold-standard diagnostic method like DXA or CT to confirm sarcopenia; diagnosis relied on clinical criteria and functional tests. There was no healthy control group; all participants had at least probable sarcopenia, so the tool cannot distinguish sarcopenic from non-sarcopenic individuals. The specificity of the rectus femoris cutoff (35.2%) is low, meaning many patients without severe sarcopenia might be incorrectly flagged as severe if relying solely on this threshold. Single-center design limits generalizability to other populations or settings.
Declared interests
The authors report no involvement in the research by any sponsor that could have influenced the outcome of this work.
The easy way to misread this
Do not use the 10.3 mm cutoff as a standalone diagnostic for severe sarcopenia because its specificity is only 35.2%. This means a positive ultrasound result is likely to identify many patients who do not actually have severe sarcopenia. It should be interpreted alongside functional tests like the Timed Up and Go.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →